Tokyo Tape
Sign in
← Qol Holdings

Quarterly report · Q1

3034.TEDINET S100ROAI
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥43.4bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥170.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥40.5bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥1.9bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥1.7bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥1.9bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥10.1bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.8bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥1.9bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥1.8bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.0bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥999m2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥104.0bnat 2023-06-30Cons.Assets
Total assets¥101.9bnat 2023-03-31Cons.Assets
Total assets¥98.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥54.7bnat 2023-06-30Cons.Liabilities
Total liabilities¥53.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥49.3bnat 2023-06-30Cons.Net assets
Net assets / equity¥48.9bnat 2023-03-31Cons.Net assets
Net assets / equity¥44.5bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥19.3bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥18.8bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥27.222023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥152.962022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥27.182022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio47.3%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio47.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥102m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥876m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2023-04-01 → 2023-06-30¥39.6bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2023-04-01 → 2023-06-30¥39.5bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥16m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2023-04-01 → 2023-06-30¥3.9bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥86m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2023-04-01 → 2023-06-30¥327m
—segment totalrevenue2023-04-01 → 2023-06-30¥43.5bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥43.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥102m
—segment totalsegment profit2023-04-01 → 2023-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥77m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥830m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue external2022-04-01 → 2022-06-30¥37.2bn
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥17m
jpcrp040300-q1r_E03476-000Health Insurance Pharmacyreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥60m
jpcrp040300-q1r_E03476-000Medical Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥349m
—segment totalrevenue2022-04-01 → 2022-06-30¥40.6bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥40.5bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥77m
—segment totalsegment profit2022-04-01 → 2022-06-30¥2.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 351
ItemContextValueUnit
Extraordinary lossPrior1YTDDuration5000000JPY
Extraordinary lossCurrentYTDDuration16000000JPY
Income before income taxesPrior1YTDDuration1755000000JPY
Income before income taxesCurrentYTDDuration1923000000JPY
Income taxes income taxesPrior1YTDDuration755000000JPY
Income taxes income taxesCurrentYTDDuration915000000JPY
Profit lossPrior1YTDDuration999000000JPY
Profit lossCurrentYTDDuration1008000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-2000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration1001000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration1010000000JPY
Profit lossPrior1YTDDuration999000000JPY
Profit lossCurrentYTDDuration1008000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration2000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration1000000JPY
Other comprehensive incomePrior1YTDDuration2000000JPY
Other comprehensive incomeCurrentYTDDuration1000000JPY
Comprehensive incomePrior1YTDDuration1002000000JPY
Comprehensive incomeCurrentYTDDuration1009000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration1004000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration1012000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-2000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-2000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember37157000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3392000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember40550000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration40550000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember17000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember60000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember77000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-77000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember37175000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3453000000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember40628000000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-77000000JPY
Net salesPrior1YTDDuration40550000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember2139000000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember349000000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember2488000000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-830000000JPY
Operating incomePrior1YTDDuration1658000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember39547000000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E03476-000MedicalRelatedReportableSegmentMember3856000000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember43403000000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration43403000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E03476-000HealthInsurancePharmacyReportableSegmentsMember16000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass